12-123533452-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_178314.5(RILPL1):c.31G>A(p.Ala11Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000019 in 1,529,296 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000017 ( 0 hom. )
Consequence
RILPL1
NM_178314.5 missense
NM_178314.5 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 4.38
Genes affected
RILPL1 (HGNC:26814): (Rab interacting lysosomal protein like 1) Predicted to enable protein dimerization activity. Predicted to be involved in several processes, including cilium assembly; epithelial cell morphogenesis; and protein transport from ciliary membrane to plasma membrane. Located in cytosol; nucleoplasm; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.08609125).
BS2
High AC in GnomAd4 at 5 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RILPL1 | NM_178314.5 | c.31G>A | p.Ala11Thr | missense_variant | 1/7 | ENST00000376874.9 | NP_847884.2 | |
RILPL1 | NM_001319243.2 | c.31G>A | p.Ala11Thr | missense_variant | 1/8 | NP_001306172.1 | ||
RILPL1 | XM_047428787.1 | c.31G>A | p.Ala11Thr | missense_variant | 1/7 | XP_047284743.1 | ||
RILPL1 | XM_047428788.1 | c.31G>A | p.Ala11Thr | missense_variant | 1/3 | XP_047284744.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RILPL1 | ENST00000376874.9 | c.31G>A | p.Ala11Thr | missense_variant | 1/7 | 1 | NM_178314.5 | ENSP00000366070 | P3 | |
RILPL1 | ENST00000636882.1 | c.31G>A | p.Ala11Thr | missense_variant | 1/8 | 5 | ENSP00000490668 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152024Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
5
AN:
152024
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000516 AC: 7AN: 135752Hom.: 0 AF XY: 0.0000678 AC XY: 5AN XY: 73800
GnomAD3 exomes
AF:
AC:
7
AN:
135752
Hom.:
AF XY:
AC XY:
5
AN XY:
73800
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000174 AC: 24AN: 1377272Hom.: 0 Cov.: 32 AF XY: 0.0000296 AC XY: 20AN XY: 676230
GnomAD4 exome
AF:
AC:
24
AN:
1377272
Hom.:
Cov.:
32
AF XY:
AC XY:
20
AN XY:
676230
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152024Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74254
GnomAD4 genome
AF:
AC:
5
AN:
152024
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
74254
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2023 | The c.31G>A (p.A11T) alteration is located in exon 1 (coding exon 1) of the RILPL1 gene. This alteration results from a G to A substitution at nucleotide position 31, causing the alanine (A) at amino acid position 11 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.
MutationTaster
Benign
N
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.
REVEL
Benign
Sift
Uncertain
D;.
Sift4G
Benign
T;.
Polyphen
B;.
Vest4
MutPred
Gain of glycosylation at A11 (P = 0.0227);Gain of glycosylation at A11 (P = 0.0227);
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at